Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Guangzhou Pharma to Set Up JV with Dr. Ferid Murad, a Nobel Winner

publication date: Nov 25, 2013
Guangzhou Pharmaceutical Holdings, the controlling shareholder of Guangzhou Baiyunshan Pharma, will establish a JV with Dr. Ferid Murad, a biochemist who won the Nobel Prize in Physiology or Medicine in 1998. Dr. Murad showed that nitric oxide played a role in the cell signaling process that causes vascular dilation. He continues to work on nitric oxide as a treatment for cancer and arthritis. The JV will be known as Wanglaoji & Murad Biotechnology Co., Ltd. More details....

Stock Symbol: (SHA: 600332)

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital